Stocks · News reference
Filed: 2026-06-30 AccNo: 0001193125-26-290788 Size: 260 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Lumexa Imaging Holdings (NASDAQ:LMRI) affirms FY2026 Adj EPS guidance from $0.71-$0.77 to $0.71-$0.77 vs $0.62 analyst estimate. Raises FY2026 sales outlook from $1.045 billion-$1.090 billion to $1.045 billion-$1.097
Read original at benzingaLumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.16 by 25 percent. The company reported quarterly sales of $264.200 million which beat
Read original at benzingaLumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint venture with Hospital for Special Surgery (HSS), world leader in
Read original at benzinga